TerminatedNCT01131572
N-acetylcysteine in Eating disorders
Medication studyAges 18–65United States
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- MasonSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateFebruary 2010
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 11
- Sponsor
- Lindner Center of HOPE
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01131572
- Official title
Show the full official title
N-acetylcysteine in Bulimia Nervosa
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Mason
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Lindner Center of HOPE.
Does this study involve medication?
Yes. The study involves medication, including N-acetylcysteine NAC.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as terminated.
